🚀 VC round data is live in beta, check it out!
- Public Comps
- QUIA PHARMA
QUIA PHARMA Valuation Multiples
Discover revenue and EBITDA valuation multiples for QUIA PHARMA and similar public comparables like Eli Lilly, Johnson & Johnson, AbbVie, Roche and more.
QUIA PHARMA Overview
About QUIA PHARMA
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.
Founded
2012
HQ

Employees
4
Website
Sectors
Financials (FY)
Market Cap
—
QUIA PHARMA Stock Performance
QUIA PHARMA has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQUIA PHARMA Valuation Multiples
QUIA PHARMA Financial Valuation Multiples
As of March 11, 2026, QUIA PHARMA has market cap of —.
Equity research analysts estimate QUIA PHARMA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified QUIA PHARMA Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


QUIA PHARMA Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eli Lilly | XXX | XXX | XXX | XXX | XXX | XXX |
| Johnson & Johnson | XXX | XXX | XXX | XXX | XXX | XXX |
| AbbVie | XXX | XXX | XXX | XXX | XXX | XXX |
| Roche | XXX | XXX | XXX | XXX | XXX | XXX |
| Novartis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
QUIA PHARMA M&A Activity
QUIA PHARMA acquired XXX companies to date.
Last acquisition by QUIA PHARMA was on XXXXXXXX, XXXXX. QUIA PHARMA acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by QUIA PHARMA
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialQUIA PHARMA Investment Activity
QUIA PHARMA invested in XXX companies to date.
QUIA PHARMA made its latest investment on XXXXXXXX, XXXXX. QUIA PHARMA invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by QUIA PHARMA
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout QUIA PHARMA
| When was QUIA PHARMA founded? | QUIA PHARMA was founded in 2012. |
| Where is QUIA PHARMA headquartered? | QUIA PHARMA is headquartered in Sweden. |
| How many employees does QUIA PHARMA have? | As of today, QUIA PHARMA has over 4 employees. |
| Is QUIA PHARMA publicly listed? | Yes, QUIA PHARMA is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of QUIA PHARMA? | QUIA PHARMA trades under QUIA ticker. |
| When did QUIA PHARMA go public? | QUIA PHARMA went public in 2005. |
| Who are competitors of QUIA PHARMA? | QUIA PHARMA main competitors are Eli Lilly, Johnson & Johnson, AbbVie, Roche. |
| Is QUIA PHARMA profitable? | No, QUIA PHARMA is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.